Reported Reactions

Devices › Thoracolumbosacral pedicle screw system

Device brand name · Matrix locking cap

Ti Matrix Locking Cap: medical device reports filed with FDA

489 reports name it, 2011–2021. Manufacturer given most often on reports: Synthes Brandywine. Product code NKB.

489
device reports naming the brand
0% of all MAUDE reports · about 32 a year
0
reports, 12 months to August 2026
0 in the 12 months before
15.3%
classified as malfunction
41.2% across the product code
1.2%
classified as death, as reported
6 reports · not verified by FDA

FDA's MAUDE database holds 489 reports that name the brand "Ti Matrix Locking Cap" (matrix locking cap), received between March 2011 and April 2021; the manufacturer given most often on reports is Synthes Brandywine. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (83.4%), malfunction (15.3%) and death (1.2%); across all thoracolumbosacral pedicle screw system reports (product code NKB) death is recorded in 0.3% and malfunction in 41.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are device slipped (20.2%), break (16.2%) and device dislodged or dislocated (13.7%). The patient problems coded most often are pain, failure of implant and nonunion/delayed-union bone fracture. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Ti Matrix Locking Cap was received in the five years to August 2026; the latest was received in April 2021.

By year received

0841682011: 4120112012: 16820122013: 14820132014: 5620142015: 4420152016: 820162017: 920172019: 1120192021: 42021

Event type and report source

Event type, as classified on the report

Death1.2%6
Injury83.4%408
Malfunction15.3%75
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%489
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 24,738 reports carrying product code NKB. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device slipped9920.2%6%
Breakthe device broke7916.2%21.4%
Device dislodged or dislocated6713.7%4.4%
Difficult to removethe device was hard to remove5711.7%1.3%
Detachment of device component4910%2.8%
Migration or expulsion of device418.4%4.6%
Insufficient device problem information377.6%3.2%
Loose or intermittent connection336.7%4.6%
Device operates differently than expectedthe device behaved unexpectedly234.7%2.3%
Malposition of device224.5%1.1%
Sticking122.5%0.3%
Naturally worn102%0.2%
Fitting problem91.8%0.4%
Positioning problem81.6%0.5%
Unintended collision81.6%0%
Unstable81.6%0.2%
Fracturea broken bone71.4%8.1%
Material fragmentation61.2%0.8%
Connection problema connection problem51%0.2%
Mechanical jam51%0.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified8818%
Failure of implant295.9%
Nonunion/delayed-union bone fracture234.7%
Bone fracture(s)183.7%
Post operative wound infection142.9%
Impaired healingslow healing132.7%
Sedationdrowsiness from a medicine91.8%
Numbnessnumbness81.6%
Stenosis71.4%
Tissue damage71.4%
Deaththe patient died; cause not stated by this term61.2%
Device embedded in tissue or plaque61.2%
Complaint, ill-defined51%
Falla fall51%
Vascular system (circulation), impaired40.8%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTi Matrix Locking CapProduct code NKBAll MAUDE reports
Reports48924,73826,136,888
Share of that pool—2%0%
Classified as death, per 1,000 reports1239
Classified as injury83.4%58.1%36.2%
Classified as malfunction15.3%41.2%62.3%
Filed by the manufacturer100%99.2%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NKB

BrandReportsLatest 12 monthsClassified as death
CD HORIZON Spinal System9,7876340.3%
Blocker45600%
Nuvasive Reline System46881.5%
Single-Inner Setscrew454190%
Closure Top440270%
CD HORIZON SOLERA VOYAGER Spinal System7752160.1%
5 5 Exp Verse Unitized Set Scr309110%
Open Implant Closure Top27700%
Unknown Mono/Polyaxial Screws39000%
CD HORIZON SOLERA Spinal System320680%
Verse Correction Key28830%
Xia 3 Titanium Blocker34070%
Mis Single Inner Setscw20990.5%
Unknown_Spine_Product596240%
Ti 12-Point Nut-11mm17400%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Ti Matrix Locking Cap reports

How many FDA reports name Ti Matrix Locking Cap?

489 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (83.4%), malfunction (15.3%) and death (1.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device slipped (20.2%), break (16.2%), device dislodged or dislocated (13.7%), difficult to remove (11.7%) and detachment of device component (10%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Ti Matrix Locking Cap was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.